Kevin Tang - Nov 23, 2021 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role
Exit Filing
Signature
/s/ Kevin Tang
Stock symbol
APVO
Transactions as of
Nov 23, 2021
Transactions value $
-$10,368,236
Form type
4
Date filed
11/26/2021, 12:02 PM
Previous filing
Nov 22, 2021
Next filing
Dec 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APVO Common Stock Sale -$2.18M -161K -17.51% $13.52* 760K Nov 23, 2021 By LP F1, F2
transaction APVO Common Stock Sale -$1.55M -125K -16.38% $12.45* 635K Nov 23, 2021 By LP F2, F3
transaction APVO Common Stock Sale -$886K -75.5K -11.88% $11.74* 560K Nov 23, 2021 By LP F2, F4
transaction APVO Common Stock Sale -$1.67M -149K -26.63% $11.19* 411K Nov 23, 2021 By LP F2, F5
transaction APVO Common Stock Sale -$531K -50.9K -12.39% $10.43* 360K Nov 23, 2021 By LP F2, F6
transaction APVO Common Stock Sale -$2.01M -200K -55.56% $10.07* 160K Nov 23, 2021 By LP F2, F7
transaction APVO Common Stock Sale -$1.54M -160K -100% $9.60* 0 Nov 23, 2021 By LP F2, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Kevin Tang is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The prices reported in Column 4 are weighted average prices. These shares were sold in multiple transactions at prices ranging from $13.29 to $13.77. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 1 and 3 through 8 herein.
F2 The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.
F3 The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $11.97 to $12.90.
F4 The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $11.59 to $11.89.
F5 The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $10.74 to $11.67.
F6 The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $10.31 to $10.64.
F7 The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $9.59 to $10.34.
F8 The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $9.50 to $10.20.